Compounds > gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and dimyristoylphosphatidylcholine

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with dimyristoylphosphatidylcholine in 1 studies

Compound Research Comparison

Studies
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Trials
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Recent Studies (post-2010)
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Studies
(dimyristoylphosphatidylcholine)		Trials
(dimyristoylphosphatidylcholine)		Recent Studies (post-2010) (dimyristoylphosphatidylcholine)
638312433,4741855

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chou, JJ; Dev, J; Fu, Q; Piai, A1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and dimyristoylphosphatidylcholine

ArticleYear
Optimal Bicelle Size q for Solution NMR Studies of the Protein Transmembrane Partition.
    Chemistry (Weinheim an der Bergstrasse, Germany), 2017, Jan-26, Volume: 23, Issue:6

    Topics: Dimyristoylphosphatidylcholine; fas Receptor; Heterocyclic Compounds; Humans; Lipid Bilayers; Magnetic Resonance Spectroscopy; Organometallic Compounds; Phospholipid Ethers; Recombinant Proteins

2017